SCHEMBL6092140

SCHEMBL6092140

CCc1cccc2c(C(C)(c3ccc(O)cc3)c3ccc(F)cc3)c[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 1/20 0.42
NR3C1 P04150 3/20 0.41
PGR P06401 3/20 0.41
NR3C2 P08235 3/20 0.41
AR P10275 3/20 0.41
KDR P35968 1/20 0.41
TSHR P16473 1/20 0.38
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1349569 0.77 NR3C1 (0.45) ALDH1A1KMT2ALMNAHTTNR3C1
SCHEMBL1349509 0.76 NR3C1 (0.37) ALDH1A1LMNAHTTNR3C1PGR
SCHEMBL14667571 0.74 ALDH1A1 (0.53) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL6089364 0.74 NR3C1 (0.39) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL1348899 0.70 NR3C1 (0.41) NR3C1PGRNR3C2AR
SCHEMBL1350158 0.69 NR3C1 (0.35) NR3C1PGRNR3C2AR
SCHEMBL3151375 0.67 ESR1 (0.64) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL1349908 0.67 NR3C1 (0.70) NR3C1PGRNR3C2ARKDR
SCHEMBL6091351 0.67 NR3C1 (0.48) NR3C1PGRNR3C2AR
SCHEMBL13715228 0.67 ALDH1A1 (0.57) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors ELI LILLY AND COMPANY (US) 2006-10-19 US disclosed
CN-1742007-A Indole-derivative modulators of steroid hormone nuclear receptors LILLY CO ELI (US) 2006-03-01 CN disclosed
EP-1597254-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS Eli Lilly and Company (US) 2005-11-23 EP disclosed
WO-2004067529-A1 INDOLE-DERIVATIVE MODULATORS OF STEROID HORMONE NUCLEAR RECEPTORS ELI LILLY AND COMPANY (US) 2004-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235222-A1 Indole-derivative modulators of steroid hormone nuclear receptors NR3C2, NR5A1, MC2R ALDH1A1 1544/4885MEN1 3034/4885KMT2A 3358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.